4th Annual 2024 AFCC Global Biobased Economy Conference

Few biotechnology innovations make it through the Valley of Death to market.  A company’s intellectual property is its number one asset, and it is invaluable in the path to success.  Developing a patent portfolio while navigating third party patents is ripe with challenges and opportunities. Should companies pursue patent or trade secret protection for their innovative technologies?  Are certain aspects of the company’s technologies even eligible for patent protection?  When should filings be made and how often?  What are the IP implications of industry or university collaborations?  Do you have freedom to operate in view of third party patents?  The presentation highlighted best practices to maximize IP protection and minimize invalidation and infringement risks along the road to market.